Learning Objectives:
1: Outline the evidence supporting the link between the gut microbiome and cancer.
2: Highlight novel therapeutic strategies to modulate the gut microbiome to optimize efficacy of PD-1 based immunotherapy
Session date:
04/08/2021 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Carolina Soto Chervin, MD, PhD